An opinion piece on the subject of psychedelic-assisted therapy was published in the Boston Herald this morning. And the article, authored by Healing Hearts, Changing Minds founder Robert Ansin, sheds a light on the importance of this emerging field of medical science and the critical role it can play in shaping the future of mental health care. You can read the full article here.

​

In his op-ed, Ansin cites the long history of innovation Massachusetts is famous for, while calling for lawmakers to embrace emerging this potential mental health revolution. "Our health system was ranked number one in the nation last year by the Commonwealth Fund," Ansin states. "But remaining number one requires more than protecting what we already do well. It requires embracing emerging science when the evidence demands it. Psychedelic assisted therapy is one of those areas."

​

"Studies at leading institutions have shown promising outcomes for post-traumatic stress disorder, treatment resistant depression, addiction, trauma, and end-of-life distress," Ansin continues. "Here in Massachusetts, clinicians at Massachusetts General Hospital have established a dedicated Center for the Neuroscience of Psychedelics. Researchers at Harvard Medical School and other academic institutions across the Commonwealth are contributing to a growing body of peer-reviewed evidence."

​

HHCM is helping fund the future of this important field of medical science 

Ansin goes on to explain the fundraising work we're doing at Healing Hearts, Changing Minds, and the important impact this funding can make.

 

"I have personally experienced the transformative potential of psychedelic assisted therapy," Ansin explains. "That experience led me to found Healing Hearts, Changing Minds, a nonprofit dedicated to funding research into psychedelic assisted therapy for compassionate end of life care and other mental health needs. In our most recent grant round, we awarded more than $566,000 to seven universities and organizations, including the Mayo Clinic, which is studying psilocybin for patients with brain tumors."

​

If you'd like to contribute to our efforts at Healing Hearts, Changing Minds, please visit our donors page and learn how you can help us fund the future of psychedelic-assisted therapy research.

​

​

​

​

 

​